To better understand the clinical importance of the analysed markers, their expression was correlated against laboratory parameters (WBC #, LYMPH #, MONO #, NEUTR #, PLT #, LDH, IgA, IgG, IgM, β2-microglobulin, haemoglobin), patient age, time to treatment, and immunological parameters (the percentage of B cells [CD19+], CLL B cells [CD19+/CD5+]). Here, CD19 is linked to B-cell chronic lymphocytic leukemia.